Management of acute attacks of hereditary angioedema: role of ecallantide
Hannah Duffey,1 Rafael Firszt1,2 1Department of Pediatrics, 2Division of Allergy, Immunology and Rheumatology, University of Utah, Salt Lake City, UT, USA Abstract: Hereditary angioedema (HAE) is characterized as an episodic swelling disorder with autosomal dominant inheritance. Clinical features i...
Main Authors: | Duffey H, Firszt R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | Journal of Blood Medicine |
Online Access: | http://www.dovepress.com/management-of-acute-attacks-of-hereditary-angioedema-role-of-ecallanti-peer-reviewed-article-JBM |
Similar Items
-
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
by: Farkas H, et al.
Published: (2011-05-01) -
Ecallantide for the Treatment of Hereditary Angiodema in Adults
by: Michael Lunn, et al.
Published: (2011-01-01) -
Ecallantide for the Treatment of Hereditary Angiodema in Adults
by: Michael Lunn, et al.
Published: (2011-05-01) -
Management of acute attacks of hereditary angioedema: potential role of icatibant
by: Hilary J Longhurst
Published: (2010-09-01) -
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
by: Michihiro Hide, et al.
Published: (2021-01-01)